| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | cell cortex | APC TBCB SPTBN5 RAI14 PLEKHH2 BSN FAM110C PDLIM2 EPB41L2 PHLDB2 | 4.23e-05 | 371 | 116 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | anchoring junction | CDHR2 PKP4 APC AMBRA1 SRCIN1 FAT1 NOX1 ABI2 PKP3 SCN5A RAI14 PDLIM2 CDH7 ARHGAP21 EPB41L2 PHLDB2 | 9.76e-05 | 976 | 116 | 16 | GO:0070161 |
| Domain | PH | 8.67e-05 | 229 | 115 | 8 | PF00169 | |
| Domain | Multidrug-R_assoc | 2.24e-04 | 4 | 115 | 2 | IPR005292 | |
| Domain | ARM-type_fold | 2.50e-04 | 339 | 115 | 9 | IPR016024 | |
| Domain | PH_dom-like | DOCK11 WDFY4 SPTBN5 SBF1 ARHGAP25 PLEKHH2 PREX1 ARHGAP21 EPB41L2 PHLDB2 | 3.03e-04 | 426 | 115 | 10 | IPR011993 |
| Domain | PH | 3.26e-04 | 278 | 115 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 3.34e-04 | 279 | 115 | 8 | PS50003 | |
| Domain | PH_domain | 3.42e-04 | 280 | 115 | 8 | IPR001849 | |
| Domain | UIM | 4.19e-04 | 24 | 115 | 3 | PS50330 | |
| Domain | UIM_dom | 4.74e-04 | 25 | 115 | 3 | IPR003903 | |
| Domain | Na_trans_cytopl | 5.55e-04 | 6 | 115 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 5.55e-04 | 6 | 115 | 2 | IPR024583 | |
| Domain | Cadherin_CS | 5.69e-04 | 109 | 115 | 5 | IPR020894 | |
| Domain | CADHERIN_1 | 6.71e-04 | 113 | 115 | 5 | PS00232 | |
| Domain | Cadherin | 6.71e-04 | 113 | 115 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 6.98e-04 | 114 | 115 | 5 | PS50268 | |
| Domain | - | 6.98e-04 | 114 | 115 | 5 | 2.60.40.60 | |
| Domain | - | DOCK11 SPTBN5 SBF1 ARHGAP25 PLEKHH2 PREX1 ARHGAP21 EPB41L2 PHLDB2 | 7.03e-04 | 391 | 115 | 9 | 2.30.29.30 |
| Domain | CA | 7.26e-04 | 115 | 115 | 5 | SM00112 | |
| Domain | Cadherin-like | 7.55e-04 | 116 | 115 | 5 | IPR015919 | |
| Domain | Plakophilin/d_Catenin | 7.74e-04 | 7 | 115 | 2 | IPR028435 | |
| Domain | Cadherin | 8.16e-04 | 118 | 115 | 5 | IPR002126 | |
| Domain | Arm | 9.01e-04 | 31 | 115 | 3 | PF00514 | |
| Domain | PH_dom-spectrin-type | 1.32e-03 | 9 | 115 | 2 | IPR001605 | |
| Domain | Na_channel_asu | 1.64e-03 | 10 | 115 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.64e-03 | 10 | 115 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.64e-03 | 10 | 115 | 2 | PF06512 | |
| Domain | ARM_REPEAT | 1.90e-03 | 40 | 115 | 3 | PS50176 | |
| Domain | ARM | 1.90e-03 | 40 | 115 | 3 | SM00185 | |
| Domain | WWE | 2.38e-03 | 12 | 115 | 2 | PF02825 | |
| Domain | WWE-dom | 2.38e-03 | 12 | 115 | 2 | IPR004170 | |
| Domain | WWE | 2.38e-03 | 12 | 115 | 2 | PS50918 | |
| Domain | UBA | 2.51e-03 | 44 | 115 | 3 | IPR015940 | |
| Domain | Armadillo | 3.03e-03 | 47 | 115 | 3 | IPR000225 | |
| Domain | UBA | 3.03e-03 | 47 | 115 | 3 | PS50030 | |
| Domain | - | 4.56e-03 | 333 | 115 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.71e-03 | 335 | 115 | 7 | IPR015943 | |
| Domain | TF_T-box | 4.81e-03 | 17 | 115 | 2 | IPR001699 | |
| Domain | TBOX | 4.81e-03 | 17 | 115 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 4.81e-03 | 17 | 115 | 2 | IPR018186 | |
| Domain | - | 4.81e-03 | 17 | 115 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 4.81e-03 | 17 | 115 | 2 | PS50252 | |
| Domain | T-box | 4.81e-03 | 17 | 115 | 2 | PF00907 | |
| Domain | TBOX_1 | 4.81e-03 | 17 | 115 | 2 | PS01283 | |
| Domain | TBOX_2 | 4.81e-03 | 17 | 115 | 2 | PS01264 | |
| Domain | UIM | 5.39e-03 | 18 | 115 | 2 | PF02809 | |
| Domain | Lig_chan-Glu_bd | 5.39e-03 | 18 | 115 | 2 | PF10613 | |
| Domain | Glu/Gly-bd | 5.39e-03 | 18 | 115 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 5.39e-03 | 18 | 115 | 2 | SM00918 | |
| Domain | Iontro_rcpt | 5.39e-03 | 18 | 115 | 2 | IPR001320 | |
| Domain | Iono_rcpt_met | 5.39e-03 | 18 | 115 | 2 | IPR001508 | |
| Domain | Lig_chan | 5.39e-03 | 18 | 115 | 2 | PF00060 | |
| Domain | PBPe | 5.39e-03 | 18 | 115 | 2 | SM00079 | |
| Pubmed | NOP56 DOCK11 PKP4 UBR4 APC GRIN2A HUWE1 LUZP1 SBF1 ABI2 MTOR TMED10 BSN MGA ARHGAP21 CEP170B NUP153 EPB41L2 PHLDB2 SMG6 | 7.78e-11 | 963 | 117 | 20 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK11 MARK3 KIAA0232 APC GLCCI1 LUZP1 FAM83H LIMK2 IGF1R ALMS1 SBF1 MTOR RAI14 ARHGAP21 ABTB2 CEP170B EPB41L2 PHLDB2 | 6.85e-10 | 861 | 117 | 18 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TSHZ2 STXBP5L MARK3 KIAA0232 PPFIA2 DYNC2I1 SRCIN1 HUWE1 ADCY1 ATF6 PPP2R3A IGF1R BRI3BP GLI2 PKP3 ANKIB1 RAI14 SEMA6A SERINC5 SCARA3 CEP170B SMG6 | 4.66e-09 | 1489 | 117 | 22 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | REPS1 UBR4 AMBRA1 GRID1 HUWE1 MLLT10 POM121C FAM83H FAT1 IGF1R SBF1 MTOR SCN5A SCARA3 PREX1 ARHGAP21 ABTB2 CEP170B SMG6 | 5.42e-09 | 1105 | 117 | 19 | 35748872 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | NOP56 PPFIA2 PKP4 PODXL2 SRCIN1 GRIN2A LUZP1 BSN CEP170B EPB41L2 | 6.59e-09 | 231 | 117 | 10 | 16452087 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOP56 RB1 PKP4 UBR4 SMC4 AMBRA1 HUWE1 LUZP1 FAM83H TBCB SBF1 NUP133 ANKIB1 RAI14 MGA RIOK2 EPB41L2 PHLDB2 PARP12 | 1.32e-07 | 1353 | 117 | 19 | 29467282 |
| Pubmed | ABCC1 MARK3 PKP4 IGF1R SBF1 ABI2 RAI14 SEMA6A ARHGAP21 EPB41L2 PHLDB2 | 1.97e-07 | 421 | 117 | 11 | 36976175 | |
| Pubmed | REPS1 MARK3 APC DYNC2I1 GRIN2A LUZP1 SBF1 TRAPPC10 RAI14 ARHGAP21 CEP170B | 2.44e-07 | 430 | 117 | 11 | 32581705 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 7.95e-07 | 218 | 117 | 8 | 33378226 | |
| Pubmed | 9.19e-07 | 153 | 117 | 7 | 10718198 | ||
| Pubmed | REPS1 MARK3 PKP4 SMC4 APC HUWE1 LUZP1 FAM83H TBCB IGF1R PKP3 TRAPPC10 RAI14 MED26 MGA PHLDB2 PARP12 | 9.77e-07 | 1247 | 117 | 17 | 27684187 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.27e-06 | 232 | 117 | 8 | 25515538 | |
| Pubmed | 1.61e-06 | 418 | 117 | 10 | 34709266 | ||
| Pubmed | NOP56 UBR4 USP24 SMC4 APC LUZP1 ATF6 FAT1 BRI3BP PKP3 RAI14 ECEL1 EEA1 TMED10 RIOK2 SCARA3 EPB41L2 | 1.67e-06 | 1297 | 117 | 17 | 33545068 | |
| Pubmed | REPS1 MARK3 RBM4B PKP4 SMC4 APC MRPS35 LUZP1 SBF1 ABI2 RBM15B RAI14 TMED10 PREX1 PDLIM2 CEP170B EPB41L2 SMG6 | 2.69e-06 | 1497 | 117 | 18 | 31527615 | |
| Pubmed | 2.83e-06 | 347 | 117 | 9 | 17114649 | ||
| Pubmed | 3.23e-06 | 67 | 117 | 5 | 29254152 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | NOP56 MARK3 PKP4 SRCIN1 LUZP1 FAM83H PKP3 RAI14 FAM110C ARHGAP21 PHLDB2 | 3.47e-06 | 565 | 117 | 11 | 25468996 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ABCC1 MARK3 PKP4 FAT1 NOX1 MTOR SEMA6A FAM110C ARHGAP21 EPB41L2 PHLDB2 | 3.71e-06 | 569 | 117 | 11 | 30639242 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 5.24e-06 | 281 | 117 | 8 | 28706196 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 5.31e-06 | 375 | 117 | 9 | 32788342 | |
| Pubmed | KRT1 MAP9 MARK3 PPFIA2 PKP4 APC SRCIN1 GRIN2A LUZP1 SBF1 LRIG1 TRAPPC10 RAI14 BSN ARHGAP21 CEP170B EPB41L2 | 6.17e-06 | 1431 | 117 | 17 | 37142655 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KIAA0232 PKP4 APC DYNC2I1 LUZP1 FAM83H TBCB PPP2R3A ALMS1 ABI2 MGA ARHGAP21 CEP170B | 6.29e-06 | 853 | 117 | 13 | 28718761 |
| Pubmed | KRT1 MAP9 NOP56 PCDHGC4 PCDHGB7 PPFIA2 UBR4 SMC4 MRPS35 LUZP1 TBCB CFAP45 SCN9A EEA1 BSN PREX1 ARHGAP21 | 6.82e-06 | 1442 | 117 | 17 | 35575683 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24833705 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 30236984 | ||
| Pubmed | Overexpression of motor protein KIF17 enhances spatial and working memory in transgenic mice. | 1.12e-05 | 2 | 117 | 2 | 12391294 | |
| Pubmed | Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. | 1.12e-05 | 2 | 117 | 2 | 10835642 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 16585182 | ||
| Pubmed | p600, a unique protein required for membrane morphogenesis and cell survival. | 1.12e-05 | 2 | 117 | 2 | 16214886 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 10811882 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26617795 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 27183435 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24092877 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26861708 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 30821042 | ||
| Pubmed | GSK1904529A, a Potent IGF-IR Inhibitor, Reverses MRP1-Mediated Multidrug Resistance. | 1.12e-05 | 2 | 117 | 2 | 28266043 | |
| Pubmed | TMP21 regulates autophagy by modulating ROS production and mTOR activation. | 1.12e-05 | 2 | 117 | 2 | 31472964 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 30554401 | ||
| Pubmed | Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells. | 1.12e-05 | 2 | 117 | 2 | 23899556 | |
| Pubmed | REPS1 NOP56 DOCK11 PKP4 SMC4 MRPS35 HUWE1 ARHGAP25 MGA PREX1 ARHGAP21 NUP153 EPB41L2 | 1.34e-05 | 916 | 117 | 13 | 32203420 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ABCC1 UBR4 USP24 SMC4 HUWE1 POM121C ATF6 BRI3BP LRIG1 MTOR NUP133 TMED10 NUP153 | 1.80e-05 | 942 | 117 | 13 | 31073040 |
| Pubmed | 2.11e-05 | 446 | 117 | 9 | 24255178 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT1 NOP56 MARK3 PKP4 SMC4 MRPS35 LUZP1 FAM83H PKP3 NUP133 RBM15B RAI14 NUP153 EPB41L2 PHLDB2 | 2.16e-05 | 1257 | 117 | 15 | 36526897 |
| Pubmed | RB1 PKP4 AMBRA1 POM121C LUZP1 FAM83H LIMK2 FAT1 ALMS1 SCN5A MGA PDLIM2 CEP170B PHLDB2 | 2.41e-05 | 1116 | 117 | 14 | 31753913 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | UBR4 SMC4 MRPS35 AMBRA1 HUWE1 LUZP1 SBF1 MTOR PKP3 NUP133 TMED10 ABTB2 NUP153 | 2.54e-05 | 974 | 117 | 13 | 28675297 |
| Pubmed | STBD1 REPS1 NOP56 MARK3 USP24 SMC4 APC RAI14 ARHGAP21 NUP153 EPB41L2 | 2.83e-05 | 708 | 117 | 11 | 39231216 | |
| Pubmed | STXBP5L PPFIA2 UBR4 USP24 APC MRPS35 SRCIN1 GRIN2A HUWE1 TBCB ABI2 BSN CEP170B EPB41L2 | 3.01e-05 | 1139 | 117 | 14 | 36417873 | |
| Pubmed | 3.19e-05 | 263 | 117 | 7 | 34702444 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 3.31e-05 | 363 | 117 | 8 | 14691545 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 25591908 | ||
| Pubmed | USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity. | 3.36e-05 | 3 | 117 | 2 | 31527800 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 20696710 | ||
| Pubmed | Plakophilin3 loss leads to increased adenoma formation and rectal prolapse in APCmin mice. | 3.36e-05 | 3 | 117 | 2 | 34823217 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 18439156 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 10702291 | ||
| Pubmed | E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling. | 3.36e-05 | 3 | 117 | 2 | 28137882 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 28315335 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 28713243 | ||
| Pubmed | Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier. | 3.36e-05 | 3 | 117 | 2 | 31813825 | |
| Pubmed | p53 suppresses carcinoma progression by inhibiting mTOR pathway activation. | 3.36e-05 | 3 | 117 | 2 | 24469052 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 28343662 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 18697743 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 11439001 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 26364612 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 14871261 | ||
| Pubmed | IGF-2 mediates intestinal mucosal hyperplasia in retinoblastoma protein (Rb)-deficient mice. | 3.36e-05 | 3 | 117 | 2 | 23845628 | |
| Pubmed | ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway. | 3.36e-05 | 3 | 117 | 2 | 33994864 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 37224811 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 37166989 | ||
| Pubmed | ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. | 3.36e-05 | 3 | 117 | 2 | 18650380 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 26584640 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 31365870 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 17845218 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 29133593 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 20038812 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 30956133 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 20628002 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 18832169 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 30689807 | ||
| Pubmed | Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. | 3.36e-05 | 3 | 117 | 2 | 22729283 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 19020730 | ||
| Pubmed | HUWE1 controls MCL1 stability to unleash AMBRA1-induced mitophagy. | 3.36e-05 | 3 | 117 | 2 | 31434979 | |
| Pubmed | BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas. | 3.36e-05 | 3 | 117 | 2 | 33628587 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NOP56 APC MRPS35 DYNC2I1 AMBRA1 GLCCI1 FAM83H RBAK NUP133 RAI14 EEA1 CEP170B NUP153 MYBL1 | 3.51e-05 | 1155 | 117 | 14 | 20360068 |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 3.81e-05 | 111 | 117 | 5 | 22558309 | |
| Pubmed | 4.11e-05 | 486 | 117 | 9 | 20936779 | ||
| Pubmed | 4.59e-05 | 493 | 117 | 9 | 15368895 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 4.65e-05 | 190 | 117 | 6 | 15161933 | |
| Pubmed | 4.78e-05 | 191 | 117 | 6 | 31177093 | ||
| Pubmed | 4.81e-05 | 496 | 117 | 9 | 31343991 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 4.88e-05 | 497 | 117 | 9 | 36774506 | |
| Pubmed | 5.35e-05 | 503 | 117 | 9 | 16964243 | ||
| Pubmed | NOP56 UBR4 USP24 SMC4 HUWE1 FAM83H MTOR NUP133 NUP153 EPB41L2 | 6.18e-05 | 638 | 117 | 10 | 33239621 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 6.26e-05 | 639 | 117 | 10 | 23443559 | |
| Pubmed | [Role of PTEN protein in multidrug resistance of prostate cancer cells]. | 6.70e-05 | 4 | 117 | 2 | 18702307 | |
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 25709106 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 12595570 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 23459592 | ||
| Pubmed | TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation. | 6.70e-05 | 4 | 117 | 2 | 37324936 | |
| Interaction | SFN interactions | CCDC125 KRT1 DOCK11 MARK3 KIAA0232 APC LUZP1 FAM83H IGF1R ALMS1 MTOR PKP3 EEA1 ARHGAP21 CEP170B EPB41L2 PHLDB2 | 3.99e-07 | 692 | 115 | 17 | int:SFN |
| Interaction | YWHAE interactions | CCDC125 STBD1 DOCK11 MARK3 KIAA0232 APC SRCIN1 HUWE1 GLCCI1 LUZP1 FAM83H TBCB IGF1R SBF1 ABI2 MTOR RAI14 MGA FAM110C ARHGAP21 CEP170B EPB41L2 PHLDB2 | 5.56e-07 | 1256 | 115 | 23 | int:YWHAE |
| Interaction | YWHAH interactions | CCDC125 DOCK11 MARK3 KIAA0232 APC HUWE1 GLCCI1 LUZP1 FAM83H TBCB ALMS1 SBF1 ABI2 MTOR RBM15B TRAPPC10 RAI14 ARHGAP21 CEP170B EPB41L2 PHLDB2 | 9.95e-07 | 1102 | 115 | 21 | int:YWHAH |
| Interaction | MKRN2 interactions | RB1 RBM4B APC ADCY1 TBCB ALMS1 MTOR GLI2 SEMA6A PLEKHH2 PDLIM2 PARP12 | 2.09e-06 | 385 | 115 | 12 | int:MKRN2 |
| Interaction | YWHAG interactions | DOCK11 MARK3 KIAA0232 USP24 APC HUWE1 USP37 GLCCI1 LUZP1 FAM83H IGF1R ALMS1 SBF1 MTOR RBM15B TRAPPC10 RAI14 ARHGAP21 CEP170B EPB41L2 PHLDB2 | 7.03e-06 | 1248 | 115 | 21 | int:YWHAG |
| Interaction | MAPRE1 interactions | MAP9 REPS1 APC LUZP1 FAM83H TBCB ALMS1 PKP3 NUP133 MED26 ARHGAP21 CEP170B NUP153 | 7.58e-06 | 514 | 115 | 13 | int:MAPRE1 |
| Interaction | C11orf52 interactions | ABCC1 MARK3 PKP4 IGF1R SBF1 RAI14 SEMA6A ARHGAP21 EPB41L2 PHLDB2 | 1.18e-05 | 311 | 115 | 10 | int:C11orf52 |
| Interaction | ARHGEF7 interactions | 2.80e-05 | 153 | 115 | 7 | int:ARHGEF7 | |
| Interaction | SLC6A4 interactions | REPS1 MARK3 APC DYNC2I1 GRIN2A LUZP1 SBF1 TRAPPC10 RAI14 ARHGAP21 CEP170B | 4.14e-05 | 437 | 115 | 11 | int:SLC6A4 |
| Interaction | RHOQ interactions | ABCC1 DOCK11 MARK3 PKP4 MUC13 FAT1 SBF1 MTOR RAI14 SEMA6A ARHGAP21 | 4.58e-05 | 442 | 115 | 11 | int:RHOQ |
| Interaction | TFDP3 interactions | 5.15e-05 | 36 | 115 | 4 | int:TFDP3 | |
| Interaction | RAC3 interactions | ABCC1 STBD1 DOCK11 MARK3 PKP4 PODXL2 MUC13 FAT1 SBF1 ABI2 RAI14 ARHGAP21 PHLDB2 | 5.29e-05 | 619 | 115 | 13 | int:RAC3 |
| Interaction | LAMP1 interactions | ABCC1 STBD1 MARK3 PKP4 UBR4 HUWE1 IGF1R SBF1 ABI2 MTOR RAI14 ARHGAP21 EPB41L2 | 7.90e-05 | 644 | 115 | 13 | int:LAMP1 |
| Interaction | C2CD4B interactions | 1.15e-04 | 44 | 115 | 4 | int:C2CD4B | |
| Interaction | RHOF interactions | ABCC1 DOCK11 MARK3 PKP4 PODXL2 MUC13 POM121C FAT1 SBF1 ABI2 MTOR RAI14 ARHGAP21 | 1.23e-04 | 673 | 115 | 13 | int:RHOF |
| Interaction | RAC2 interactions | ABCC1 STBD1 DOCK11 MARK3 PKP4 MUC13 FAT1 SBF1 ABI2 MTOR PKP3 ARHGAP21 PHLDB2 | 1.24e-04 | 674 | 115 | 13 | int:RAC2 |
| Cytoband | 16p13.1 | 3.85e-05 | 4 | 117 | 2 | 16p13.1 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.85e-05 | 206 | 84 | 7 | 682 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.52e-04 | 9 | 84 | 2 | 1203 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.04e-03 | 43 | 84 | 3 | 409 | |
| GeneFamily | ATP binding cassette subfamily C | 1.61e-03 | 13 | 84 | 2 | 807 | |
| GeneFamily | Cadherin related | 2.77e-03 | 17 | 84 | 2 | 24 | |
| GeneFamily | T-boxes | 3.11e-03 | 18 | 84 | 2 | 766 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 6.11e-06 | 27 | 117 | 4 | M1391 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 6.11e-06 | 27 | 117 | 4 | MM1135 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ABCC1 RB1 MARK3 PKP4 USP24 APC FAT1 PPP2R3A IGF1R LRIG1 NUP133 ZBTB18 NUP153 MYBL1 | 2.88e-05 | 856 | 117 | 14 | M4500 |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN | 3.10e-05 | 198 | 117 | 7 | M7261 | |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP | 3.21e-05 | 199 | 117 | 7 | M5692 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP | 3.31e-05 | 200 | 117 | 7 | M6352 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.58e-07 | 183 | 117 | 7 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.71e-07 | 192 | 117 | 7 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 9.47e-07 | 198 | 117 | 7 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 9.47e-07 | 198 | 117 | 7 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 9.47e-07 | 198 | 117 | 7 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-06 | 158 | 117 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-06 | 158 | 117 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-06 | 168 | 117 | 6 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.69e-06 | 169 | 117 | 6 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | Club_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.69e-06 | 169 | 117 | 6 | 03b303af8a26c6ff196507fe24f5bd3d75d7b1af | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.66e-06 | 178 | 117 | 6 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Proliferative_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.91e-06 | 179 | 117 | 6 | d24513a404c9b1d37dd47aa1cdb5713b64b88f89 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 7.91e-06 | 179 | 117 | 6 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.91e-06 | 179 | 117 | 6 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.43e-06 | 181 | 117 | 6 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.97e-06 | 183 | 117 | 6 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 9.26e-06 | 184 | 117 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 9.55e-06 | 185 | 117 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.55e-06 | 185 | 117 | 6 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 9.55e-06 | 185 | 117 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.84e-06 | 186 | 117 | 6 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.84e-06 | 186 | 117 | 6 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.08e-05 | 189 | 117 | 6 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.08e-05 | 189 | 117 | 6 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.11e-05 | 190 | 117 | 6 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.11e-05 | 190 | 117 | 6 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-05 | 191 | 117 | 6 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 193 | 117 | 6 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 1.25e-05 | 194 | 117 | 6 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | ASK440-Endothelial-Lymphatic|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.25e-05 | 194 | 117 | 6 | 4aa68e39e36094359dfbedf1e9bdf3ea5c32ed1a | |
| ToppCell | ASK440-Endothelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.29e-05 | 195 | 117 | 6 | 1cdaab17866a1e5170e0f6bfcc69134425fdd8df | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 196 | 117 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | distal-Endothelial-Lymphatic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.33e-05 | 196 | 117 | 6 | 3e8a20e1d163dcbd3bbd99fe179d54af02298af0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.36e-05 | 197 | 117 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | ILEUM-non-inflamed-(7)_ACKR1+_endothelial_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.40e-05 | 198 | 117 | 6 | f8a6a75c9f2fbe32a22b14b6a029411c73c09f68 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.44e-05 | 199 | 117 | 6 | 97052c28e354833901f28d339b09f97f50a5b752 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-05 | 199 | 117 | 6 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | cb00760ae75c30b1cb8526534aabd4ffc7c21000 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.49e-05 | 200 | 117 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.49e-05 | 200 | 117 | 6 | 891a80cbde575f81f3466217175f41e1d4f66d5e | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-05 | 200 | 117 | 6 | c55efd997392e99068b673542f56f1a209c5a6c8 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.49e-05 | 200 | 117 | 6 | c761d1742653a83e69e4c03d6e10e5e53f28bebb | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Bronchial_vessel|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.49e-05 | 200 | 117 | 6 | a18817d36b2b30a32e1513d36174bf98dfea2a92 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.49e-05 | 200 | 117 | 6 | dcbc91ed3351bafd72cf71d7025cbbdc8361d9b9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-05 | 200 | 117 | 6 | 71979bbcc035d5b8882f1502b5a8ef248aaba45a | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 1.62e-05 | 203 | 117 | 6 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.00e-05 | 125 | 117 | 5 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | 21-Trachea-Immune-Immune|Trachea / Age, Tissue, Lineage and Cell class | 2.79e-05 | 134 | 117 | 5 | 4f0465324cc5b443ebadb68aef63be79b74f6ff9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.68e-05 | 142 | 117 | 5 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Pik3r3_(Pdgfa)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.69e-05 | 71 | 117 | 4 | 2220e1b02baa71961cfc85536bafeb313e588bf3 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Pik3r3_(Pdgfa)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.69e-05 | 71 | 117 | 4 | cc5de8bbcfefa2bf93cc137c74b49a745d5da229 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.81e-05 | 143 | 117 | 5 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 148 | 117 | 5 | dfd3f2c4b884ea9e23831a242a89ac985b409640 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.42e-05 | 154 | 117 | 5 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 5.59e-05 | 155 | 117 | 5 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | VE-CD8-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 6.49e-05 | 160 | 117 | 5 | 255d2a150bfe19ee3d4d34533feb9c37ce73d225 | |
| ToppCell | facs-Lung-24m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.89e-05 | 162 | 117 | 5 | 4e418bea07e35038b32a78a1e6632b6ec1208cdc | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.47e-05 | 85 | 117 | 4 | 159b3ac93490c3e4918ea61f8ede7add9e63ca40 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-05 | 165 | 117 | 5 | 1703d3eb644b3c743ad3c5532b1d29ea010c79c8 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.73e-05 | 166 | 117 | 5 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.73e-05 | 166 | 117 | 5 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.95e-05 | 167 | 117 | 5 | 5c82d801e3b7d7c6c967a73b94b2ee2a8da1fd6e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.41e-05 | 169 | 117 | 5 | bddb28a8b9afbe4a68f082e82caf96a6666fc674 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.41e-05 | 169 | 117 | 5 | 5ce46bac8e767feec7ecdc61689de225c49bd3f7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 8.65e-05 | 170 | 117 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-05 | 170 | 117 | 5 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-05 | 170 | 117 | 5 | 87cac555f16b6c2ef3d1b3a00f992d8bf2237b50 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-05 | 170 | 117 | 5 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 8.89e-05 | 171 | 117 | 5 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 9.13e-05 | 172 | 117 | 5 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 9.13e-05 | 172 | 117 | 5 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.39e-05 | 173 | 117 | 5 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.39e-05 | 173 | 117 | 5 | 07798461d12d04f3dabff03481c999cb07c5af2f | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.39e-05 | 173 | 117 | 5 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 175 | 117 | 5 | 3f1b2e23fec953148fb0711e523c463adb07dca4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-05 | 175 | 117 | 5 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 176 | 117 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.02e-04 | 176 | 117 | 5 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 176 | 117 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.02e-04 | 176 | 117 | 5 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.05e-04 | 177 | 117 | 5 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 177 | 117 | 5 | 9edfb50856f5e10672ab194ce0076d6a190e64de | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 177 | 117 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Esophagus_Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.06e-04 | 93 | 117 | 4 | 4ab8c28f7c47129ac633bcfdc7ccc8f7793464d5 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 178 | 117 | 5 | aa44851653d276226b922ee14dd1fc8d1a844cdf | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 178 | 117 | 5 | 888add8935ef3aef9b6693c5698e9d1842e66337 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 178 | 117 | 5 | 43eda32af2e5e28a92421612d0a4c21e5427a772 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-04 | 179 | 117 | 5 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| ToppCell | facs-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 179 | 117 | 5 | bbfbfb32773346080127055b5aafa36bbf7d0942 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Neuronal-Cortical_neuron|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 94 | 117 | 4 | a752c80fb2e83cffa22a00d7e98c24406ee41908 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 180 | 117 | 5 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 180 | 117 | 5 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 1.16e-04 | 181 | 117 | 5 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 181 | 117 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 181 | 117 | 5 | 57f82f54e20e19aa17a2ea22af22e3bc8965d622 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 181 | 117 | 5 | 8855812c85ef45c1be6bd511619b2dfe5e441264 | |
| ToppCell | Control-Myeloid-DC1|Control / Condition, Lineage and Cell class | 1.16e-04 | 181 | 117 | 5 | 5a2a1f017ad23baed9972c68b4a46f4c618ef21a | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 1.16e-04 | 181 | 117 | 5 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 182 | 117 | 5 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| Disease | Dysosteosclerosis | 1.51e-05 | 2 | 115 | 2 | C0432262 | |
| Disease | CD166 antigen measurement | 8.99e-05 | 4 | 115 | 2 | EFO_0020245 | |
| Disease | Colorectal Neoplasms | 1.10e-04 | 277 | 115 | 7 | C0009404 | |
| Disease | Paroxysmal atrial fibrillation | 3.72e-04 | 156 | 115 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 3.72e-04 | 156 | 115 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.72e-04 | 156 | 115 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 4.18e-04 | 160 | 115 | 5 | C0004238 | |
| Disease | epilepsy (implicated_via_orthology) | 4.55e-04 | 163 | 115 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Carcinoma, Small Cell | 5.32e-04 | 9 | 115 | 2 | C0262584 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.64e-04 | 10 | 115 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.64e-04 | 10 | 115 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 9.69e-04 | 12 | 115 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | ventricular enlargement measurement | 1.14e-03 | 13 | 115 | 2 | EFO_0010570 | |
| Disease | forehead morphology measurement | 1.53e-03 | 15 | 115 | 2 | EFO_0007844 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.53e-03 | 15 | 115 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.53e-03 | 15 | 115 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.53e-03 | 15 | 115 | 2 | C0154091 | |
| Disease | Malignant neoplasm of skin | 1.60e-03 | 59 | 115 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.60e-03 | 59 | 115 | 3 | C0037286 | |
| Disease | lymphocyte count | ABCC1 SLC29A3 PCDHGC4 PCDHGB7 RB1 MARK3 KIAA0232 ALMS1 PKP3 HFM1 CALCRL PREX1 PARP12 SMG6 | 1.69e-03 | 1464 | 115 | 14 | EFO_0004587 |
| Disease | Adrenocortical carcinoma | 2.21e-03 | 18 | 115 | 2 | C0206686 | |
| Disease | Carcinoma of bladder | 2.21e-03 | 18 | 115 | 2 | C0699885 | |
| Disease | colorectal cancer, inflammatory bowel disease | 2.47e-03 | 19 | 115 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | resting heart rate | 2.80e-03 | 149 | 115 | 4 | EFO_0004351 | |
| Disease | gestational age, birth measurement | 3.01e-03 | 21 | 115 | 2 | EFO_0005112, EFO_0006921 | |
| Disease | aortic measurement | 3.07e-03 | 251 | 115 | 5 | EFO_0020865 | |
| Disease | atrial fibrillation | 3.39e-03 | 371 | 115 | 6 | EFO_0000275 | |
| Disease | Glioblastoma | 3.68e-03 | 79 | 115 | 3 | C0017636 | |
| Disease | body surface area | 3.75e-03 | 643 | 115 | 8 | EFO_0022196 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GNLQRTSSQRSTLTY | 451 | Q99569 | |
| RNRYRTRSTSSAGSN | 251 | Q86US8 | |
| TLRTINASYDSDQAT | 121 | O75871 | |
| YRRTVNTFSQSVSSL | 46 | Q8WY22 | |
| SSRSYQTNTADTVRF | 226 | Q00973 | |
| RFTNDLLNSSSAIYS | 161 | Q5T601 | |
| TGIQIASSSSYSNRE | 1886 | Q8TCU4 | |
| SSLRDYTPASRSENQ | 826 | Q9P2G1 | |
| AHYRSSSTRSIDTQT | 336 | Q86VQ1 | |
| TQTYASQTRSESSSQ | 741 | Q8TC27 | |
| TSSISRNSGSELQVY | 531 | P18850 | |
| YTQSSRSGTVSQEAL | 661 | Q9C0C7 | |
| SNTRRRQQGSDYTST | 1246 | Q9Y4F5 | |
| TASVNQRNRTYSSSG | 231 | Q9NYB9 | |
| ATYSRSTSQNLDSGT | 496 | P06400 | |
| LSQLSYSTSSSKRQS | 901 | Q9P0K7 | |
| SSDRRNSLEGYSRSV | 556 | Q8NDT2 | |
| LESRTLSSYVSVSAQ | 496 | Q9Y5F8 | |
| YSRSRQATDGSLASI | 126 | Q9Y5S8 | |
| YSTTSSCQARASQVR | 481 | Q9NZ53 | |
| YSARESLSEVQSLSS | 4356 | Q14517 | |
| RERSSFYSLTSSNIS | 281 | Q8WUM0 | |
| SFSSRVVSLSEYRQS | 266 | O00567 | |
| AITARSARQRSSEYS | 31 | Q49MG5 | |
| SYLSSQGTLSDRQET | 841 | Q96JA1 | |
| ASTTNDSGYRARISQ | 691 | Q8IWI9 | |
| RSESLRCSSSYSQQI | 311 | P53671 | |
| RGDSSSSQRTDYQKS | 186 | Q13201 | |
| SSVSASAFASTYRQQ | 156 | Q08397 | |
| SLAQYSATTAREISR | 2086 | Q9UPA5 | |
| RALYFSDSSSQLNTS | 621 | Q8WVS4 | |
| SSSAASNRSRNKARY | 11 | Q9UL16 | |
| RYSGRTQAQTRQAST | 516 | O43491 | |
| SSRSRNTTAADTYNI | 751 | P08069 | |
| SAGIINYQRRTTSSS | 21 | P04264 | |
| ETTYRNRQDTSDLTS | 421 | Q92628 | |
| TSRSGNQVSEYISRT | 251 | Q08493 | |
| EQSPTYLNTRSSSNR | 131 | A6NHS7 | |
| LVAYINNSRSSSAAS | 256 | P10070 | |
| DVGSNSISSYRLSSN | 161 | Q9Y5F7 | |
| SELSQASAATRNSLY | 326 | Q9BQ04 | |
| YRSLTRQSSDFDTQS | 1991 | Q7Z6Z7 | |
| SRNEIIQSYLSRQSS | 481 | O95402 | |
| IQSYLSRQSSLLSSS | 486 | O95402 | |
| ADLSRYNDQASSSRI | 921 | Q06190 | |
| SLTVSLDDRNSSRYV | 246 | O95672 | |
| QSQRLDYSSSSSEAN | 391 | Q8IVE3 | |
| RQAARRSTSTLYSQF | 1741 | O95248 | |
| RSTSTLYSQFQTAES | 1746 | O95248 | |
| YGATQARRLSTASSV | 351 | Q9H0J9 | |
| SRNAITSSYSSTRGI | 386 | A8CG34 | |
| STISSYLSDLRNRNA | 1171 | A2PYH4 | |
| QYASSEATISQLRSE | 261 | Q15075 | |
| LRNRSSFSTNVVYTT | 546 | Q08828 | |
| TTLNLFTVDQSYRSR | 1036 | Q9BYE9 | |
| NLTCTTNTTEDNYSR | 131 | Q01344 | |
| RISNYRRQSSTVDSN | 91 | Q86Z20 | |
| QSSTRSSVSQYNRLD | 1261 | Q5JSL3 | |
| LARHRVTSYTSSSVN | 331 | P25024 | |
| STNSNAYTQRSSTDF | 946 | Q86V48 | |
| QRSVSSSQKQRRYSD | 406 | P27448 | |
| SSYTANLAAFLTVSR | 646 | Q9ULK0 | |
| SSNSPVRYSIDRNTD | 406 | Q9ULB5 | |
| ARLSSATANALYSSN | 1021 | Q6ZRV2 | |
| GLQRSQSDLSSRYSA | 196 | Q1W6H9 | |
| QNYTRLFSGLRTTST | 256 | Q6AZY7 | |
| SNSEALRSASYTVST | 411 | Q16602 | |
| EQARRYLSTYTATSS | 731 | P10243 | |
| TNDSYRFSASRRSTE | 191 | Q3KNS1 | |
| SSRLQRLDNSTVRTY | 1241 | O75334 | |
| SRSNSENIASNYFRS | 941 | Q9P2E2 | |
| RSRTRTDSYSAGQSV | 2441 | P42345 | |
| QRQLSSSSSYSGDIS | 911 | P33527 | |
| SSTRSLGTLYSQVSR | 571 | Q9BVN2 | |
| ARTLRAFSTAVYSAT | 16 | P82673 | |
| TYRTTSSSLRADQEA | 16 | Q9BZD2 | |
| YRRDVTSAINLSASS | 131 | P0C7P3 | |
| SATTAIEIRRQSSSY | 261 | Q96D71 | |
| QLRRLESASYSSVCS | 1111 | O95255 | |
| SNRGQHSISYTLSRS | 121 | Q8N2H9 | |
| NRDSVLSYTSVRSNS | 1176 | Q8TCU6 | |
| SYDSVTRATSDNLQV | 1976 | Q14524 | |
| DSEYSKVRLNRSSSS | 1111 | Q15858 | |
| ISYQSSSTEERRLNS | 406 | Q02383 | |
| RNRSYVFSSLATSAV | 311 | Q8IVW8 | |
| SENINLRTRKYSSSS | 231 | Q86SQ0 | |
| GSVRTYTESQSSLRS | 106 | Q96JY6 | |
| TASYTNVNITDFSRS | 191 | Q9NRC6 | |
| EENRENSYNRSRSSS | 806 | Q9Y2K9 | |
| NSYNRSRSSSISSID | 811 | Q9Y2K9 | |
| SLRTSFSQSRYSVVQ | 751 | Q8N961 | |
| RGSNRSYDQSLSDSS | 206 | P55197 | |
| YKRSSNDSLNSVSSS | 956 | P25054 | |
| SSSLNATYRSLVARE | 46 | Q9UBY8 | |
| RAFAYERQASSSSSR | 211 | Q9Y446 | |
| RSSSSNFLNYDLTLR | 311 | Q9H3R2 | |
| TSNSRSYSEVSRNES | 131 | O95210 | |
| SVRSLSTYSAAALQS | 431 | Q9C0H9 | |
| RDTNESTNTRVLYFS | 176 | P49755 | |
| STSLAETYNRLTNQA | 431 | O95935 | |
| SISQLISSDGSYART | 146 | Q9NYW8 | |
| QLDRASSSLYVAFST | 491 | Q9H2E6 | |
| RQLSDSQRTSTYDNV | 491 | P42331 | |
| SSYFSSQDVLRSNLV | 256 | Q99592 | |
| TSTTRSSSDALQGRY | 331 | Q86VE9 | |
| SSSLNTFRSEKRYSR | 16 | Q99426 | |
| SQRDTVLSTLYSSLN | 2001 | Q6ZS81 | |
| SNFYVSRTACRDNTS | 181 | Q9NTJ3 | |
| LSAQSYGVTSSTARR | 296 | P49790 | |
| STRSASVSRRYLFEN | 746 | Q9NRE2 | |
| QYRTRTLSITSSGSA | 476 | Q9BVS4 | |
| QRESGLSSSSYELSQ | 226 | Q96JE7 | |
| SRTSQKETSRQLSYS | 126 | Q86T82 | |
| EKSSYRQLSVSDRSS | 1291 | Q9UPU5 | |
| ESRAVVYSNTREQSS | 836 | P48553 | |
| VYSNTREQSSEAALR | 841 | P48553 | |
| SSTSASVNRYILQLA | 3786 | Q5T4S7 | |
| RLDSLRAASQSTTDY | 411 | Q5T5U3 | |
| ANNQLFSSSYDRTAR | 106 | Q86TI4 | |
| SYIQSFRDRQTGSSL | 316 | Q66K66 | |
| VNDSYLRSSLRSTAS | 1396 | Q12879 |